To test if β-lap increases the antigen-specific T cell response, splenocytes from MC38 tumor-bearing mice were collected 10 days after the initial β-lap treatment and an IFNγ ELISPOT assay was performed to measure the effector function of activated T cells. Here, IFNG is linked to neoplasm.